Structure-Guided Redesign Increases the Propensity of HIV Env To Generate Highly Stable Soluble Trimers

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Journal of Virology

• Publication date

  2015-12-30

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1128/JVI.02652-15PMID 26719252PMCID PMC4810649
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• D-101 HIV-1 neutralizing antibodies induced by native-like envelope trimers

  2016cited by this paper
• Crystal structure , conformational fixation , and entry-related interactions of mature ligand-free HIV-1 Env

  2016cited by this paper
• Cleavage-independent HIV-1 Env trimers engineered as soluble native spike mimetics for vaccine design.

  2015cited by this paper
• Well-Ordered Trimeric HIV-1 Subtype B and C Soluble Spike Mimetics Generated by Negative Selection Display Native-like Properties

  2015influential reference
• Design and structure of two HIV-1 clade C SOSIP.664 trimers that increase the arsenal of native-like Env immunogens

  2015cited by this paper
• Single-Chain Soluble BG505.SOSIP gp140 Trimers as Structural and Antigenic Mimics of Mature Closed HIV-1 Env

  2015cited by this paper
• Crystal structure, conformational fixation, and entry-related interactions of mature ligand-free HIV-1 Env

  2015cited by this paper
• A Native-Like SOSIP.664 Trimer Based on an HIV-1 Subtype B env Gene

  2015cited by this paper
• HIV-1 neutralizing antibodies induced by native-like envelope trimers

  2015cited by this paper
• Stable, uncleaved HIV-1 envelope glycoprotein gp140 forms a tightly folded trimer with a native-like structure

  2014cited by this paper
• Faculty Opinions recommendation of Cryo-EM structure of a fully glycosylated soluble cleaved HIV-1 envelope trimer.

  2014cited by this paper
• Recombinant HIV envelope trimer selects for quaternary-dependent antibodies targeting the trimer apex

  2014cited by this paper
• Structure and immune recognition of trimeric prefusion HIV-1 Env

  2014cited by this paper
• Structural delineation of a quaternary, cleavage-dependent epitope at the gp41-gp120 interface on intact HIV-1 Env trimers.

  2014cited by this paper
• Crystal Structure of a Soluble Cleaved HIV-1 Envelope Trimer

  2013cited by this paper
• Influences on Trimerization and Aggregation of Soluble, Cleaved HIV-1 SOSIP Envelope Glycoprotein

  2013cited by this paper
• Cryo-EM Structure of a Fully Glycosylated Soluble Cleaved HIV-1 Envelope Trimer

  2013cited by this paper
• A Next-Generation Cleaved, Soluble HIV-1 Env Trimer, BG505 SOSIP.664 gp140, Expresses Multiple Epitopes for Broadly Neutralizing but Not Non-Neutralizing Antibodies

  2013cited by this paper
• Pre-fusion structure of trimeric HIV-1 envelope glycoprotein determined by cryo-electron microscopy

  2013cited by this paper
• HIV-1 Neutralizing Antibodies Display Dual Recognition of the Primary and Coreceptor Binding Sites and Preferential Binding to Fully Cleaved Envelope Glycoproteins

  2012cited by this paper
• A trimeric, V2-deleted HIV-1 envelope glycoprotein vaccine elicits potent neutralizing antibodies but limited breadth of neutralization in human volunteers.

  2011cited by this paper
• Broad neutralization coverage of HIV by multiple highly potent antibodies

  2011cited by this paper
• A clustering approach to multireference alignment of single-particle projections in electron microscopy.

  2010cited by this paper
• Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1

  2010cited by this paper
• Appion: an integrated, database-driven pipeline to facilitate EM image processing.

  2009cited by this paper
• DoG Picker and TiltPicker: software tools to facilitate particle selection in single particle electron microscopy.

  2009cited by this paper
• Broad and Potent Neutralizing Antibodies from an African Donor Reveal a New HIV-1 Vaccine Target

  2009cited by this paper
• Broad HIV-1 neutralization mediated by CD4-binding site antibodies

  2007cited by this paper
• Automated molecular microscopy: the new Leginon system.

  2005cited by this paper
• Antigenicity and Immunogenicity of a Synthetic Human Immunodeficiency Virus Type 1 Group M Consensus Envelope Glycoprotein

  2005cited by this paper
• Biochemical and Immunogenic Characterization of Soluble Human Immunodeficiency Virus Type 1 Envelope Glycoprotein Trimers Expressed by Semliki Forest Virus

  2005cited by this paper
• Structural basis of tyrosine sulfation and VH-gene usage in antibodies that recognize the HIV type 1 coreceptor-binding site on gp120.

  2004cited by this paper
• Purification, Characterization, and Immunogenicity of a Soluble Trimeric Envelope Protein Containing a Partial Deletion of the V2 Loop Derived from SF162, an R5-Tropic Human Immunodeficiency Virus Type 1 Isolate

  2003cited by this paper
• Highly Stable Trimers Formed by Human Immunodeficiency Virus Type 1 Envelope Glycoproteins Fused with the Trimeric Motif of T4 Bacteriophage Fibritin

  2002cited by this paper
• Stabilization of the Soluble, Cleaved, Trimeric Form of the Envelope Glycoprotein Complex of Human Immunodeficiency Virus Type 1

  2002cited by this paper
• Enhancing the Proteolytic Maturation of Human Immunodeficiency Virus Type 1 Envelope Glycoproteins

  2002cited by this paper
• Improved Elicitation of Neutralizing Antibodies against Primary Human Immunodeficiency Viruses by Soluble Stabilized Envelope Glycoprotein Trimers

  2001cited by this paper
• Modifications That Stabilize Human Immunodeficiency Virus Envelope Glycoprotein Trimers in Solution

  2000cited by this paper
• Characterization of Stable, Soluble Trimers Containing Complete Ectodomains of Human Immunodeficiency Virus Type 1 Envelope Glycoproteins

  2000cited by this paper
• A Recombinant Human Immunodeficiency Virus Type 1 Envelope Glycoprotein Complex Stabilized by an Intermolecular Disulfide Bond between the gp120 and gp41 Subunits Is an Antigenic Mimic of the Trimeric Virion-Associated Structure

  2000cited by this paper
• Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody

  1998cited by this paper
• Codon usage limitation in the expression of HIV-1 envelope glycoprotein.

  1996cited by this paper
• A new generation of the IMAGIC image processing system.

  1996cited by this paper
• Native oligomeric human immunodeficiency virus type 1 envelope glycoprotein elicits diverse monoclonal antibody reactivities

  1994cited by this paper
• Immunogenicity and Protective Efficacy of Oligomeric Human Immunodeficiency Virus Type 1 gp140

  year unknowncited by this paper

• Identification of a potent V3 glycan site broadly neutralizing antibody targeting an N332gp120 glycan-independent epitope

  2026cites this paper
• Heterologous combinations of VSV-GP and native-like trimers elicit autologous Tier 2 HIV antibodies in rabbits

  2025cites this paper
• Structure-guided design of native-like HIV Env Single Chain Trimers for enhanced stability, immunogenicity, and versatile vaccine delivery

  2025cites this paper
• HIV Env trimers elicit NHP apex cross-neutralizing antibodies mimicking human bNAbs

  2025cites this paper
• Identification of a broad and potent V3 glycan site bNAb targeting an N332gp120 glycan-independent epitope

  2025cites this paper
• A modification to heptad repeat 1 of gp41 improves yield and/or quality of soluble pre-fusion HIV-1 envelope glycoprotein trimers

  2025cites this paper
• Accelerated cGMP production of near-native HIV-1 Env trimers following electroporation transfection and immunogenicity analysis

  2025cites this paper
• Rapid acquisition of HIV-1 neutralization breadth in a rhesus V2 apex germline antibody mouse model after a single bolus immunization

  2025cites this paper
• Antigen persistence and TLR stimulation contribute to induction of a durable HIV-1-specific neutralizing antibody response

  2025cites this paper
• Vaccination of nonhuman primates elicits a broadly neutralizing antibody lineage targeting a quaternary epitope on the HIV-1 Env trimer.

  2025cites this paper
• Immunogenicity and Structure of stabilized HIV-1 Clade-C Env from pediatric Elite-neutralizer complexed with autologous bNAb

  2025cites this paper
• The Design and Immunogenicity of an HIV-1 Clade C Pediatric Envelope Glycoprotein Stabilized by Multiple Platforms

  2025cites this paper
• Progress and Challenges in HIV-1 Vaccine Research: A Comprehensive Overview

  2025cites this paper
• In vivo affinity maturation of mouse B cells reprogrammed to express human antibodies

  2024cites this paper
• Neutralizing antibodies elicited in macaques recognize V3 residues on altered conformations of HIV-1 Env trimer

  2024cites this paper
• Mosaic and mixed HIV-1 glycoprotein nanoparticles elicit antibody responses to broadly neutralizing epitopes

  2024cites this paper
• Design and immunogenicity of an HIV-1 clade C pediatric envelope glycoprotein stabilized by multiple platforms

  2024cites this paper
• mRNA lipid nanoparticles expressing cell-surface cleavage independent HIV Env trimers elicit autologous tier-2 neutralizing antibodies

  2024cites this paper
• Membrane HIV-1 envelope glycoproteins stabilized more strongly in a pretriggered conformation than natural virus Envs

  2024cites this paper
• Microsecond dynamics control the HIV-1 Envelope conformation

  2024cites this paper
• Trapping the HIV-1 V3 loop in a helical conformation enables broad neutralization

  2023cites this paper
• Potency and durability of T and B cell immune responses after homologous and heterologous vector delivery of a trimer-stabilized, membrane-displayed HIV-1 clade ConC Env protein

  2023cites this paper
• In vivo affinity maturation of murine B cells reprogrammed to express human antibodies

  2023cites this paper
• Triple tandem trimer immunogens for HIV-1 and influenza nucleic acid-based vaccines

  2023cites this paper
• Impact of stabilizing mutations on the antigenic profile and glycosylation of membrane-expressed HIV-1 envelope glycoprotein

  2023cites this paper
• Microsecond dynamics control the HIV-1 envelope conformation

  2023cites this paper
• Fusion of the molecular adjuvant C3d to cleavage-independent native-like HIV-1 Env trimers improves the elicited antibody response

  2023cites this paper
• Single-component multilayered self-assembling protein nanoparticles presenting glycan-trimmed uncleaved prefusion optimized envelope trimers as HIV-1 vaccine candidates

  2023cites this paper
• Multivalent display of engineered HIV-1 envelope trimers on silica nanoparticles for targeting and in vitro activation of germline VRC01 B cells.

  2022cites this paper
• A neutralizing antibody target in early HIV-1 infection was recapitulated in rhesus macaques immunized with the transmitted/founder envelope sequence

  2022influential citation
• Single-component multilayered self-assembling protein nanoparticles 1 presenting glycan-trimmed uncleaved prefusion optimized envelope trimers 2 as HIV-1 vaccine candidates 3 4

  2022influential citation
• Immunization with HIV-1 trimeric SOSIP.664 BG505 or founder virus C (FVCEnv) covalently complexed to two-domain CD4S60C elicits cross-clade neutralizing antibodies in New Zealand white rabbits

  2022cites this paper
• mRNA-encoded HIV-1 Env trimer ferritin nanoparticles induce monoclonal antibodies that neutralize heterologous HIV-1 isolates in mice

  2022cites this paper
• V2 hotspot optimized MVA vaccine expressing stabilized HIV-1 Clade C envelope Gp140 delays acquisition of heterologous Clade C Tier 2 challenges in Mamu-A*01 negative Rhesus Macaques

  2022cites this paper
• Heavy-chain CDR3-engineered B cells facilitate in vivo evaluation of HIV-1 vaccine candidates

  2022cites this paper
• Potent Induction of Envelope-Specific Antibody Responses by Virus-Like Particle Immunogens Based on HIV-1 Envelopes from Patients with Early Broadly Neutralizing Responses

  2021influential citation
• Asymmetric Structures and Conformational Plasticity of the Uncleaved Full-Length Human Immunodeficiency Virus Envelope Glycoprotein Trimer

  2021cites this paper
• Ability of nucleoside-modified mRNA to encode HIV-1 envelope trimer nanoparticles

  2021cites this paper
• Stepwise Conformational Stabilization of a HIV-1 Clade C Consensus Envelope Trimer Immunogen Impacts the Profile of Vaccine-Induced Antibody Responses

  2021cites this paper
• Engineering well-expressed, V2-immunofocusing HIV-1 envelope glycoprotein membrane trimers for use in heterologous prime-boost vaccine regimens

  2021cites this paper
• In vitro affinity maturation of broader and more-potent variants of the HIV-1–neutralizing antibody CAP256-VRC26.25

  2021cites this paper
• A reversed phase HPLC method for the quantification of HIV gp145 glycoprotein levels from cell culture supernatants.

  2021cites this paper
• Antibodies from Rabbits Immunized with HIV-1 Clade B SOSIP Trimers Can Neutralize Multiple Clade B Viruses by Destabilizing the Envelope Glycoprotein

  2021cites this paper
• Assessment of an LSDV-Vectored Vaccine for Heterologous Prime-Boost Immunizations against HIV

  2021cites this paper
• Membrane Env Liposomes Facilitate Immunization with Multivalent Full-Length HIV Spikes

  2021cites this paper
• Structurally related but genetically unrelated antibody lineages converge on an immunodominant HIV-1 Env neutralizing determinant following trimer immunization

  2021cites this paper
• Functional and Highly Cross-Linkable HIV-1 Envelope Glycoproteins Enriched in a Pretriggered Conformation

  2021cites this paper
• Convergent HIV-1 Evolution upon Targeted Destabilization of the gp120-gp41 Interface

  2021cites this paper
• Structure‐guided envelope trimer design in HIV‐1 vaccine development: a narrative review

  2021cites this paper
• A non-affinity purification process for GMP production of prefusion-closed HIV-1 envelope trimers from clades A and C for clinical evaluation.

  2021cites this paper
• Structure of Super-Potent Antibody CAP256-VRC26.25 in Complex with HIV-1 Envelope Reveals a Combined Mode of Trimer-Apex Recognition.

  2020cites this paper
• HIV-1 gp120–CD4-Induced Antibody Complex Elicits CD4 Binding Site–Specific Antibody Response in Mice

  2020cites this paper
• Structural and functional evaluation of de novo-designed, two-component nanoparticle carriers for HIV Env trimer immunogens

  2020influential citation
• Development of a 3Mut-Apex-Stabilized Envelope Trimer That Expands HIV-1 Neutralization Breadth When Used To Boost Fusion Peptide-Directed Vaccine-Elicited Responses

  2020cites this paper
• Glycopeptide epitope facilitates HIV-1 envelope specific humoral immune responses by eliciting T cell help

  2020cites this paper
• Controlling the SARS-CoV-2 Spike Glycoprotein Conformation

  2020cites this paper
• One-step sequence and structure-guided optimization of HIV-1 envelope gp140

  2020influential citation
• Oral Immunization with HIV-1 Envelope SOSIP trimers elicits systemic immune responses and cross-reactive anti-V1V2 antibodies in non-human primates

  2020cites this paper
• Controlling the SARS-CoV-2 spike glycoprotein conformation

  2020cites this paper
• Neutralizing Antibody Responses Induced by HIV-1 Envelope Glycoprotein SOSIP Trimers Derived from Elite Neutralizers

  2020cites this paper
• Efficiently cleaved HIV-1 envelopes: can they be important for vaccine immunogen development?

  2020cites this paper
• Dual Pathways of Human Immunodeficiency Virus Type 1 Envelope Glycoprotein Trafficking Modulate the Selective Exclusion of Uncleaved Oligomers from Virions

  2020cites this paper
• Automated Design by Structure-Based Stabilization and Consensus Repair to Achieve Prefusion-Closed Envelope Trimers in a Wide Variety of HIV Strains.

  2020cites this paper
• Membrane Env liposomes for immunization with HIV spikes

  2020cites this paper
• Immunofocusing and enhancing autologous Tier-2 HIV-1 neutralization by displaying Env trimers on two-component protein nanoparticles

  2020cites this paper
• Neutralizing Antibodies Induced by First-Generation gp41-Stabilized HIV-1 Envelope Trimers and Nanoparticles

  2020cites this paper
• Next-Generation Sequencing of Human Antibody Repertoires for Exploring B-cell Landscape, Antibody Discovery and Vaccine Development

  2020influential citation
• Effects of the SOS (A501C/T605C) and DS (I201C/A433C) Disulfide Bonds on HIV-1 Membrane Envelope Glycoprotein Conformation and Function

  2019cites this paper
• Structure and immunogenicity of a stabilized HIV-1 envelope trimer based on a group-M consensus sequence

  2019cites this paper
• Overcoming Steric Restrictions of VRC01 HIV-1 Neutralizing Antibodies through Immunization

  2019cites this paper
• Characterization of native-like HIV-1 gp140 glycoprotein expressed in insect cells.

  2019cites this paper
• Protein engineering and particulate display of B-cell epitopes to facilitate development of novel vaccines.

  2019cites this paper
• Capturing the inherent structural dynamics of the HIV-1 envelope glycoprotein fusion peptide

  2019cites this paper
• Disruption of the HIV-1 Envelope allosteric network blocks CD4-induced rearrangements

  2019cites this paper
• Vaccination with Glycan-Modified HIV NFL Envelope Trimer-Liposomes Elicits Broadly Neutralizing Antibodies to Multiple Sites of Vulnerability

  2019cites this paper
• Extensive dissemination and intraclonal maturation of HIV Env vaccine-induced B cell responses

  2019cites this paper
• Enhancing and shaping the immunogenicity of native-like HIV-1 envelope trimers with a two-component protein nanoparticle

  2019cites this paper
• Stabilizing HIV-1 envelope glycoprotein trimers to induce neutralizing antibodies

  2018cites this paper
• Structure-Guided Redesign Improves NFL HIV Env Trimer Integrity and Identifies an Inter-Protomer Disulfide Permitting Post-Expression Cleavage

  2018influential citation
• Increased surface expression of HIV-1 envelope is associated with improved antibody response in vaccinia prime/protein boost immunization

  2018influential citation
• Development and application of high-throughput screening methods to generate novel HIV-1 envelope immunogens

  2018cites this paper
• Structure and Immune Recognition of the HIV Glycan Shield.

  2018cites this paper
• Harnessing post-translational modifications for next-generation HIV immunogens.

  2018cites this paper
• Rational design of a trispecific antibody targeting the HIV-1 Env with elevated anti-viral activity

  2018cites this paper
• Epitope-based vaccine design yields fusion peptide-directed antibodies that neutralize diverse strains of HIV-1

  2018cites this paper
• HIV-1 vaccine design through minimizing envelope metastability

  2018cites this paper
• Coévolution entre les glycoprotéines d'enveloppe du VIH et les anticorps neutralisants à large spectre ciblant la région du glycane N332

  2018cites this paper
• Epitope-based vaccine design yields fusion peptide-directed antibodies that neutralize diverse strains of HIV-1.

  2018cites this paper
• A Universal Approach to Optimize the Folding and Stability of Prefusion-Closed HIV-1 Envelope Trimers.

  2018cites this paper
• An HIV-1 Broadly Neutralizing Antibody from a Clade C-Infected Pediatric Elite Neutralizer Potently Neutralizes the Contemporaneous and Autologous Evolving Viruses

  2018cites this paper
• Hidden Lineage Complexity of Glycan-Dependent HIV-1 Broadly Neutralizing Antibodies Uncovered by Digital Panning and Native-Like gp140 Trimer

  2017cites this paper
• Structure-based design of native-like HIV-1 envelope trimers to silence non-neutralizing epitopes and eliminate CD4 binding

  2017cites this paper
• Characterization of a stable HIV-1 B/C recombinant, soluble, and trimeric envelope glycoprotein (Env) highly resistant to CD4-induced conformational changes

  2017cites this paper
• HIV Envelope Glycoform Heterogeneity and Localized Diversity Govern the Initiation and Maturation of a V2 Apex Broadly Neutralizing Antibody Lineage

  2017cites this paper
• Improving the Expression and Purification of Soluble, Recombinant Native-Like HIV-1 Envelope Glycoprotein Trimers by Targeted Sequence Changes

  2017influential citation
• Elicitation of Robust Tier 2 Neutralizing Antibody Responses in Nonhuman Primates by HIV Envelope Trimer Immunization Using Optimized Approaches

  2017cites this paper
• Tfh cells and HIV bnAbs, an immunodominance model of the HIV neutralizing antibody generation problem

  2017cites this paper
• Antigenic characterization of the human immunodeficiency virus (HIV-1) envelope glycoprotein precursor incorporated into nanodiscs

  2017cites this paper
• Stabilized HIV-1 envelope glycoprotein trimers for vaccine use

  2017cites this paper
• Guiding the long way to broad HIV neutralization

  2017cites this paper